
MIR · NYSE
Mirion Technologies, Inc.
$14.65 -0.26 (-1.74%)
Company overview
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The company operates through two segments: Medical and Industrial. The Medical segment offers radiation oncology quality assurance and dosimetry solutions, patient safety solutions for diagnostic imaging and radiation therapy centers, radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy, and radionuclide therapy products for nuclear medicine applications, including shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation.
- Sector
- Industrials
- Industry
- Industrial - Machinery
- Exchange
- NYSE
- Market cap
- $3.6B
- Employees
- 2,800
- Headquarters
- Atlanta, GA
- Website
- mirion.com
- CEO
- Thomas D. Logan
- Listed
- August 20, 2020
- P/E
- 138.34
- Dividend yield
- 0.00%
Company financials
- Revenue
- $981M
- Gross profit
- $462M
- Operating income
- $46.5M
- EBITDA
- $201M
- Net income
- $25.1M
- EPS
- $0.11
- Total assets
- $3.5B
- Total debt
- $1.2B
- Gross margin
- 47.05%
- Net margin
- 2.56%
- Earnings yield
- 0.72%
Showing FY 2024